BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This formulation features polyethylene glycol and arginine-glycine-aspartic acid co-modified liposomes (PEG-RGD co-modified liposomes) engineered with a sterically stabilized affinity surface. The vesicular structure is composed of high-purity hydrogenated phospholipids and cholesterol that form a dense bilayer shell, while the exterior surface is co-functionalized with specific arginine-glycine-aspartic acid (RGD) peptide ligands and polyethylene glycol (PEG) polymer anchors. This dual surface modification alters the overall surface topography, surface charge density, and establishes a protective hydrophilic steric layer. The resulting vesicles exhibit high colloidal stability and provide a defined model for multi-ligand surface interaction assays in cell-free environments.
Source
Custom synthesis
Functional Group
RGD peptide
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.